News
Regeneron unveils latest 'most favored nation' drug pricing deal with White House
1+ mon, 4+ day ago (610+ words) And then there were none." With Regeneron announcing a drug-pricing deal with the White House Thursday, all 17 companies targeted in a round of letters by the Trump administration last year have agreed to play ball with the President's "most favored…...
Symbols: nasdaq:regn
Opt-In Culture: How marketing to opted-in patients transforms brand outcomes
2+ mon, 3+ week ago (389+ words) Evolving compliance standards are driving a new era of patient outreach for pharma brands'one built on patient opt-in, where reaching the exact patients you need requires a trusted, compliant approach. Join industry leaders for a candid conversation on how opted-in…...
Symbols: hcps,dtc